These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24312489)

  • 1. A simple method for assessing free brain/free plasma ratios using an in vitro model of the blood brain barrier.
    Culot M; Fabulas-da Costa A; Sevin E; Szorath E; Martinsson S; Renftel M; Hongmei Y; Cecchelli R; Lundquist S
    PLoS One; 2013; 8(12):e80634. PubMed ID: 24312489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier.
    Watson PM; Paterson JC; Thom G; Ginman U; Lundquist S; Webster CI
    BMC Neurosci; 2013 Jun; 14():59. PubMed ID: 23773766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
    Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
    Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative in vitro method to predict rate and extent of drug delivery to the brain across the blood-brain barrier.
    Mangas-Sanjuan V; González-Álvarez I; González-Álvarez M; Casabó VG; Bermejo M
    Mol Pharm; 2013 Oct; 10(10):3822-31. PubMed ID: 23977999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier.
    Berezowski V; Landry C; Dehouck MP; Cecchelli R; Fenart L
    Brain Res; 2004 Aug; 1018(1):1-9. PubMed ID: 15262198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
    Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
    Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability analysis of neuroactive drugs through a dynamic microfluidic in vitro blood-brain barrier model.
    Booth R; Kim H
    Ann Biomed Eng; 2014 Dec; 42(12):2379-91. PubMed ID: 25118670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of glutamate efflux at the blood-brain barrier: involvement of glial cells.
    Cohen-Kashi-Malina K; Cooper I; Teichberg VI
    J Cereb Blood Flow Metab; 2012 Jan; 32(1):177-89. PubMed ID: 21915136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
    Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
    Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties.
    Burkhart A; Thomsen LB; Thomsen MS; Lichota J; Fazakas C; Krizbai I; Moos T
    Fluids Barriers CNS; 2015 Aug; 12():19. PubMed ID: 26246240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness.
    Cohen-Kashi Malina K; Cooper I; Teichberg VI
    Brain Res; 2009 Aug; 1284():12-21. PubMed ID: 19501061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro blood-brain barrier model adapted to repeated-dose toxicological screening.
    Fabulas-da Costa A; Aijjou R; Hachani J; Landry C; Cecchelli R; Culot M
    Toxicol In Vitro; 2013 Sep; 27(6):1944-53. PubMed ID: 23850739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
    Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
    Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells.
    Nakagawa S; Deli MA; Nakao S; Honda M; Hayashi K; Nakaoke R; Kataoka Y; Niwa M
    Cell Mol Neurobiol; 2007 Sep; 27(6):687-94. PubMed ID: 17823866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human iPSC-Derived Blood-Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?
    Appelt-Menzel A; Oerter S; Mathew S; Haferkamp U; Hartmann C; Jung M; Neuhaus W; Pless O
    Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e122. PubMed ID: 32956578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier (BBB) toxicity and permeability assessment after L-(4-¹⁰Boronophenyl)alanine, a conventional B-containing drug for boron neutron capture therapy, using an in vitro BBB model.
    Roda E; Nion S; Bernocchi G; Coccini T
    Brain Res; 2014 Oct; 1583():34-44. PubMed ID: 25128598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells.
    Goldeman C; Ozgür B; Brodin B
    Fluids Barriers CNS; 2020 Apr; 17(1):32. PubMed ID: 32321539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between quinolone uptakes by BCECs in vitro and brain-to-plasma concentration ratios in rats.
    Liu XD; Wang DW; Xie L
    Eur J Drug Metab Pharmacokinet; 2005; 30(4):249-54. PubMed ID: 16435569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood-brain barrier.
    Jolliet P; Nion S; Allain-Veyrac G; Tilloy-Fenart L; Vanuxeem D; Berezowski V; Cecchelli R
    Pharmacol Res; 2007 Jul; 56(1):11-7. PubMed ID: 17572097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient oxygen-glucose deprivation sensitizes brain capillary endothelial cells to rtPA at 4h of reoxygenation.
    Kuntz M; Mysiorek C; Pétrault O; Boucau MC; Aijjou R; Uzbekov R; Bérézowski V
    Microvasc Res; 2014 Jan; 91():44-57. PubMed ID: 24333620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.